Beam Therapeutics Inc. (BEAM) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $139.74M | +120.0% |
| 2024 | $63.52M | -83.2% |
| 2023 | $377.71M | +520.0% |
| 2022 | $60.92M | +17.5% |
| 2021 | $51.84M | +215916.7% |
| 2020 | $24.0K | +33.3% |
| 2019 | $18.0K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $139.74M | +120.0% |
| 2024 | $63.52M | -83.2% |
| 2023 | $377.71M | +520.0% |
| 2022 | $60.92M | +17.5% |
| 2021 | $51.84M | +215916.7% |
| 2020 | $24.0K | +33.3% |
| 2019 | $18.0K | — |